AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Glimepiride 4mg
4 registrations across 3 African markets— 4 active
Markets with Glimepiride 4mg
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Glimsure 4 Uncoated Tablet | 🇿🇲Zambia | Aurobindo Pharma Limited | active | Aug 2030 |
| AMAREL - 4 Tablets | 🇷🇼Rwanda | — | active | May 2029 |
| DEXEL 4mg FILM COATED TABLETS | 🇬🇭Ghana | — | active | Dec 2026 |
| DEXEL 4mg FILM COATED TABLETS | 🇬🇭Ghana | — | active | Dec 2026 |
Glimepiride 4mg in Africa — Regulatory Overview
Glimepiride 4mg is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.